Prostate Cancer Clinical Trial
Longitudinal Advanced Prostate Cancer Cohort (LAPCC)
This study examines information from patients with prostate cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). By collecting biological samples (like blood, urine, and tissue), and health information (such as treatment, diet, and quality of life) researchers hope to learn more about prostate cancer and ways to improve outcomes in the future.
I. To create an annotated biorepository with prospectively collected blood and urine samples from men with advanced prostate cancer.
OUTLINE: This is an observational study.
Patients undergo blood and urine sample collection, complete surveys, and have their medical records reviewed on study.
* Men of all racial and ethnic groups 18 years of age or older
Men with a diagnosis of advanced (metastatic) prostate cancer who are scheduled to begin a new systemic treatment (including first or subsequent lines of therapy)
Prior participation on clinical trials is allowed
* Inability to give informed consent
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.